SkinBioTherapeutics's total assets for Q2 2023 were £1.99M, a decrease of -35.55% from the previous quarter. GB:SBTX total liabilities were £775.80K for the fiscal quarter, a 27.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.